Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis
2023 · Hepatology · 26 citations
https://doi.org/10.1097/hep.0000000000000456
M
Maxime Mallet
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
2.4K
Citations
17
h-index
20
i10-index
Maxime Mallet is an academic researcher from Inserm. The author has contributed to research in topics: Liver Disease and Transplantation & Liver Disease Diagnosis and Treatment & Organ Transplantation Techniques and Outcomes. The author has an h-index of 17, co-authored 57 publications.
ORCID: 0000-0002-5257-1302Papers by this author
worksEffect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial
2025 · Journal of Hepatology · 9 citations
https://doi.org/10.1016/j.jhep.2025.06.019
Protein-S-100-beta is increased in patients with decompensated cirrhosis admitted to ICU
2023 · Journal of Intensive Medicine · 2 citations
https://doi.org/10.1016/j.jointm.2023.08.006
SAT-071 Pre-emptive TIPS should not be contra indicated in high-risk patients with acute variceal bleeding and alcohol hepatitis
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)00919-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat